• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脂质介质诱导人黏膜上皮细胞中杀菌/通透性增加蛋白(BPI)的表达。

Lipid mediator-induced expression of bactericidal/ permeability-increasing protein (BPI) in human mucosal epithelia.

作者信息

Canny Geraldine, Levy Ofer, Furuta Glenn T, Narravula-Alipati Sailaja, Sisson Richard B, Serhan Charles N, Colgan Sean P

机构信息

Department of Veterinary Physiology, University College of Dublin, Dublin 4, Ireland.

出版信息

Proc Natl Acad Sci U S A. 2002 Mar 19;99(6):3902-7. doi: 10.1073/pnas.052533799. Epub 2002 Mar 12.

DOI:10.1073/pnas.052533799
PMID:11891303
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC122621/
Abstract

Epithelial cells which line mucosal surfaces are the first line of defense against bacterial invasion and infection. Recent studies have also indicated that epithelial cells contribute significantly to the orchestration of ongoing inflammatory processes. Here, we demonstrate that human epithelial cells express bactericidal/permeability-increasing protein (BPI), an antibacterial and endotoxin-neutralizing molecule previously associated with neutrophils. Moreover, we demonstrate that such BPI expression is transcriptionally regulated by analogs of endogenously occurring anti-inflammatory eicosanoids (aspirin-triggered lipoxins, ATLa). Initial studies to verify microarray analysis revealed that epithelial cells of wide origin (oral, pulmonary, and gastrointestinal mucosa) express BPI and each is similarly regulated by aspirin-triggered lipoxins. Studies aimed at localization of BPI revealed that such expression occurs on the cell surface of cultured epithelial cell lines and dominantly localizes to epithelia in human mucosal tissue. Functional studies employing a BPI-neutralizing anti-serum revealed that surface BPI blocks endotoxin-mediated signaling in epithelia and kills Salmonella typhimurium. These studies identify a previously unappreciated "molecular shield" for protection of mucosal surfaces against Gram-negative bacteria and their endotoxin.

摘要

排列在粘膜表面的上皮细胞是抵御细菌入侵和感染的第一道防线。最近的研究还表明,上皮细胞在正在进行的炎症过程的协调中发挥着重要作用。在此,我们证明人类上皮细胞表达杀菌/通透性增加蛋白(BPI),这是一种先前与中性粒细胞相关的抗菌和内毒素中和分子。此外,我们证明这种BPI表达受内源性抗炎类花生酸(阿司匹林触发的脂氧素,ATLa)类似物的转录调控。验证微阵列分析的初步研究表明,广泛来源(口腔、肺部和胃肠道粘膜)的上皮细胞表达BPI,并且每种细胞都受到阿司匹林触发的脂氧素的类似调控。旨在定位BPI的研究表明,这种表达发生在培养的上皮细胞系的细胞表面,并且主要定位于人类粘膜组织中的上皮细胞。使用BPI中和抗血清的功能研究表明,表面BPI可阻断上皮细胞中内毒素介导的信号传导并杀死鼠伤寒沙门氏菌。这些研究确定了一种以前未被认识的“分子屏障”,用于保护粘膜表面免受革兰氏阴性菌及其内毒素的侵害。

相似文献

1
Lipid mediator-induced expression of bactericidal/ permeability-increasing protein (BPI) in human mucosal epithelia.脂质介质诱导人黏膜上皮细胞中杀菌/通透性增加蛋白(BPI)的表达。
Proc Natl Acad Sci U S A. 2002 Mar 19;99(6):3902-7. doi: 10.1073/pnas.052533799. Epub 2002 Mar 12.
2
Expression of BPI (bactericidal/permeability-increasing protein) in human mucosal epithelia.杀菌/通透性增加蛋白(BPI)在人黏膜上皮中的表达。
Biochem Soc Trans. 2003 Aug;31(Pt 4):795-800. doi: 10.1042/bst0310795.
3
Bactericidal/permeability-increasing protein (BPI) and BPI homologs at mucosal sites.黏膜部位的杀菌/通透性增加蛋白(BPI)及其同源物
Trends Immunol. 2008 Nov;29(11):541-7. doi: 10.1016/j.it.2008.07.012.
4
Functional and biochemical characterization of epithelial bactericidal/permeability-increasing protein.上皮杀菌/通透性增加蛋白的功能与生化特性
Am J Physiol Gastrointest Liver Physiol. 2006 Mar;290(3):G557-67. doi: 10.1152/ajpgi.00347.2005. Epub 2005 Nov 10.
5
Expression and function of bactericidal/permeability-increasing protein in human genital tract epithelial cells.杀菌/通透性增加蛋白在人生殖道上皮细胞中的表达及功能
J Infect Dis. 2006 Aug 15;194(4):498-502. doi: 10.1086/505712. Epub 2006 Jul 7.
6
A peptide derived from human bactericidal/permeability-increasing protein (BPI) exerts bactericidal activity against Gram-negative bacterial isolates obtained from clinical cases of bovine mastitis.一种源自人杀菌/通透性增强蛋白(BPI)的肽,对从牛乳腺炎临床病例中分离出的革兰氏阴性菌具有杀菌活性。
Vet Microbiol. 2007 Nov 15;125(1-2):80-90. doi: 10.1016/j.vetmic.2007.05.004. Epub 2007 May 18.
7
The bactericidal/permeability-increasing protein (BPI) in infection and inflammatory disease.感染与炎症性疾病中的杀菌/通透性增加蛋白(BPI)
Clin Chim Acta. 2007 Sep;384(1-2):12-23. doi: 10.1016/j.cca.2007.07.005. Epub 2007 Jul 13.
8
The region around residue 115 of human bactericidal/permeability-increasing protein is not involved in lipopolysaccharide binding or bactericidal activity. Chemical synthesis and expression of a gene coding for the active domain and characterization of recombinant proteins.人杀菌/通透性增加蛋白115位残基周围区域不参与脂多糖结合或杀菌活性。活性结构域编码基因的化学合成与表达及重组蛋白的特性分析。
Biochem J. 1994 Mar 15;298 Pt 3(Pt 3):711-8. doi: 10.1042/bj2980711.
9
Human bactericidal/permeability-increasing protein and a recombinant NH2-terminal fragment cause killing of serum-resistant gram-negative bacteria in whole blood and inhibit tumor necrosis factor release induced by the bacteria.人杀菌/通透性增加蛋白及重组氨基末端片段可在全血中杀死血清抗性革兰氏阴性菌,并抑制该细菌诱导的肿瘤坏死因子释放。
J Clin Invest. 1992 Sep;90(3):1122-30. doi: 10.1172/JCI115930.
10
Deficient expression of bactericidal/permeability-increasing protein in immunocompromised hosts: translational potential of replacement therapy.免疫功能低下宿主杀菌/通透性增加蛋白表达不足:替代治疗的转化潜力。
Biochem Soc Trans. 2011 Aug;39(4):994-9. doi: 10.1042/BST0390994.

引用本文的文献

1
Adhesive polyelectrolyte coating through UV-triggered polymerization on PLGA particles for enhanced drug delivery to inflammatory intestinal mucosa.通过紫外光引发聚合在聚乳酸-羟基乙酸共聚物(PLGA)颗粒上制备粘附性聚电解质涂层以增强药物向炎症性肠黏膜的递送
J Nanobiotechnology. 2025 Jan 22;23(1):32. doi: 10.1186/s12951-024-03066-3.
2
Inflammation-targeted delivery of Urolithin A mitigates chemical- and immune checkpoint inhibitor-induced colitis.靶向炎症递送尿石素 A 可减轻化学和免疫检查点抑制剂诱导的结肠炎。
J Nanobiotechnology. 2024 Nov 13;22(1):701. doi: 10.1186/s12951-024-02990-8.
3
Long-chain polyunsaturated fatty acids supplementation and sepsis: a systematic review and meta-analysis.补充长链多不饱和脂肪酸与脓毒症:一项系统评价和荟萃分析
Pediatr Res. 2025 Feb;97(3):924-938. doi: 10.1038/s41390-024-03579-5. Epub 2024 Sep 19.
4
Stable Dietary Ora-Curcumin Formulation Protects from Experimental Colitis and Colorectal Cancer.稳定膳食奥卡-姜黄素配方可预防实验性结肠炎和结直肠癌。
Cells. 2024 Jun 1;13(11):957. doi: 10.3390/cells13110957.
5
Proteomics-Based Mapping of Bronchopulmonary Dysplasia-Associated Changes in Noninvasively Accessible Oral Secretions.基于蛋白质组学的无创性获取的口腔分泌物中支气管肺发育不良相关变化的图谱绘制。
J Pediatr. 2024 Jul;270:113774. doi: 10.1016/j.jpeds.2023.113774. Epub 2023 Oct 13.
6
Environmental stress and nanoplastics' effects on : regulation of immune/stress-related genes and induction of innate memory in pharynx and gut.环境应激和纳米塑料对咽和肠道中免疫/应激相关基因的调控及固有记忆的诱导作用。
Front Immunol. 2023 May 29;14:1176982. doi: 10.3389/fimmu.2023.1176982. eCollection 2023.
7
Gold nanoparticles-embedded ceria with enhanced antioxidant activities for treating inflammatory bowel disease.具有增强抗氧化活性的金纳米颗粒负载二氧化铈用于治疗炎症性肠病。
Bioact Mater. 2023 Jan 26;25:95-106. doi: 10.1016/j.bioactmat.2023.01.015. eCollection 2023 Jul.
8
Bactericidal/Permeability-Increasing Protein Downregulates the Inflammatory Response in In Vivo Models of Arthritis.杀菌/通透性增加蛋白下调关节炎动物模型中的炎症反应。
Int J Mol Sci. 2022 Oct 28;23(21):13066. doi: 10.3390/ijms232113066.
9
Orally administered titanium carbide nanosheets as anti-inflammatory therapy for colitis.口服碳化钛纳米片作为结肠炎的抗炎治疗。
Theranostics. 2022 May 9;12(8):3834-3846. doi: 10.7150/thno.70668. eCollection 2022.
10
Utility of the Specialized Pro-Resolving Mediators as Diagnostic and Prognostic Biomarkers in Disease.专门促分解介质作为疾病诊断和预后生物标志物的效用。
Biomolecules. 2022 Feb 23;12(3):353. doi: 10.3390/biom12030353.

本文引用的文献

1
Bactericidal/permeability-increasing protein in host defense and its efficacy in the treatment of bacterial sepsis.杀菌/通透性增加蛋白在宿主防御中的作用及其在细菌性败血症治疗中的疗效。
Curr Infect Dis Rep. 2007 Oct;3(5):407-12. doi: 10.1007/s11908-007-1007-y.
2
Lipid mediator class switching during acute inflammation: signals in resolution.急性炎症期间脂质介质类别转换:炎症消退中的信号
Nat Immunol. 2001 Jul;2(7):612-9. doi: 10.1038/89759.
3
Unorthodox routes to prostanoid formation: new twists in cyclooxygenase-initiated pathways.前列腺素生成的非传统途径:环氧合酶起始途径中的新变化
J Clin Invest. 2001 Jun;107(12):1481-9. doi: 10.1172/JCI13375.
4
Toll receptors in innate immunity.天然免疫中的Toll受体
Trends Cell Biol. 2001 Jul;11(7):304-11. doi: 10.1016/s0962-8924(01)02004-9.
5
Differential alteration in intestinal epithelial cell expression of toll-like receptor 3 (TLR3) and TLR4 in inflammatory bowel disease.炎症性肠病中肠道上皮细胞Toll样受体3(TLR3)和TLR4表达的差异改变
Infect Immun. 2000 Dec;68(12):7010-7. doi: 10.1128/IAI.68.12.7010-7017.2000.
6
Recombinant bactericidal/permeability-increasing protein (rBPI21) as adjunctive treatment for children with severe meningococcal sepsis: a randomised trial. rBPI21 Meningococcal Sepsis Study Group.重组杀菌/通透性增加蛋白(rBPI21)作为儿童重症脑膜炎球菌败血症辅助治疗的随机试验。rBPI21脑膜炎球菌败血症研究组。
Lancet. 2000 Sep 16;356(9234):961-7. doi: 10.1016/s0140-6736(00)02712-4.
7
A neutrophil-derived anti-infective molecule: bactericidal/permeability-increasing protein.一种源自中性粒细胞的抗感染分子:杀菌/通透性增加蛋白。
Antimicrob Agents Chemother. 2000 Nov;44(11):2925-31. doi: 10.1128/AAC.44.11.2925-2931.2000.
8
Antimicrobial proteins and peptides of blood: templates for novel antimicrobial agents.血液中的抗菌蛋白和肽:新型抗菌剂的模板
Blood. 2000 Oct 15;96(8):2664-72.
9
Lipoxin A(4) analogues inhibit leukocyte recruitment to Porphyromonas gingivalis: a role for cyclooxygenase-2 and lipoxins in periodontal disease.脂氧素A(4)类似物抑制牙龈卟啉单胞菌诱导的白细胞募集:环氧化酶-2和脂氧素在牙周疾病中的作用
Biochemistry. 2000 Apr 25;39(16):4761-8. doi: 10.1021/bi992551b.
10
Human keratinocytes that express hTERT and also bypass a p16(INK4a)-enforced mechanism that limits life span become immortal yet retain normal growth and differentiation characteristics.表达hTERT并绕过限制寿命的p16(INK4a)强制机制的人类角质形成细胞会变得永生化,但仍保留正常的生长和分化特征。
Mol Cell Biol. 2000 Feb;20(4):1436-47. doi: 10.1128/MCB.20.4.1436-1447.2000.